Global Cell and Gene Therapy Manufacturing Services Supply, Demand and Key Producers, 2023-2029

Description

The global Cell and Gene Therapy Manufacturing Services market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Gene therapy aims to treat disorders by replacing or introducing genes into cells— either inside the body (in vivo) or outside of the body (ex vivo).

This report studies the global Cell and Gene Therapy Manufacturing Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy Manufacturing Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy Manufacturing Services that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cell and Gene Therapy Manufacturing Services total market, 2018-2029, (USD Million)
Global Cell and Gene Therapy Manufacturing Services total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cell and Gene Therapy Manufacturing Services total market, key domestic companies and share, (USD Million)
Global Cell and Gene Therapy Manufacturing Services revenue by player and market share 2018-2023, (USD Million)
Global Cell and Gene Therapy Manufacturing Services total market by Type, CAGR, 2018-2029, (USD Million)
Global Cell and Gene Therapy Manufacturing Services total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cell and Gene Therapy Manufacturing Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, Lonza, Catalent, WuXi AppTec, Takara Bio Inc, Nikon Corporation and FUJIFILM Holdings Corporation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy Manufacturing Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cell and Gene Therapy Manufacturing Services Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cell and Gene Therapy Manufacturing Services Market, Segmentation by Type
    By Cell Therapy
        Allogeneic
        Autologous
        Viral Vector
    By Gene Therapy
        Non-viral Vector
        Oligonucleotides
        Viral Vector

Global Cell and Gene Therapy Manufacturing Services Market, Segmentation by Application
    Oncology Diseases
    Cardiovascular Diseases
    Orthopedic Diseases
    Ophthalmology Diseases
    Infectious Diseases
    Others

Companies Profiled:
    Thermo Fisher Scientific
    Merck KGaA
    Charles River Laboratories
    Lonza
    Catalent
    WuXi AppTec
    Takara Bio Inc
    Nikon Corporation
    FUJIFILM Holdings Corporation
    F. Hoffmann-La Roche
    Oxford Biomedica Plc
    Cell and Gene Therapy Catapult
    The Discovery Labs LLC
    RoslinCT
    JRS PHARMA
    FinVector
    ABL
    Resilience
    BioCentriq
    Porton Biopharma Limited
    Andelyn Biosciences
    Commercializing Living Therapies
    Vibalogics
    Anemocyte Srl
    ElevateBio

Key Questions Answered
1. How big is the global Cell and Gene Therapy Manufacturing Services market?
2. What is the demand of the global Cell and Gene Therapy Manufacturing Services market?
3. What is the year over year growth of the global Cell and Gene Therapy Manufacturing Services market?
4. What is the total value of the global Cell and Gene Therapy Manufacturing Services market?
5. Who are the major players in the global Cell and Gene Therapy Manufacturing Services market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Cell and Gene Therapy Manufacturing Services Introduction
    1.2 World Cell and Gene Therapy Manufacturing Services Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Cell and Gene Therapy Manufacturing Services Total Market by Region (by Headquarter Location)
        1.3.1 World Cell and Gene Therapy Manufacturing Services Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Cell and Gene Therapy Manufacturing Services Market Size (2018-2029)
        1.3.3 China Cell and Gene Therapy Manufacturing Services Market Size (2018-2029)
        1.3.4 Europe Cell and Gene Therapy Manufacturing Services Market Size (2018-2029)
        1.3.5 Japan Cell and Gene Therapy Manufacturing Services Market Size (2018-2029)
        1.3.6 South Korea Cell and Gene Therapy Manufacturing Services Market Size (2018-2029)
        1.3.7 ASEAN Cell and Gene Therapy Manufacturing Services Market Size (2018-2029)
        1.3.8 India Cell and Gene Therapy Manufacturing Services Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cell and Gene Therapy Manufacturing Services Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cell and Gene Therapy Manufacturing Services Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029)
    2.2 World Cell and Gene Therapy Manufacturing Services Consumption Value by Region
        2.2.1 World Cell and Gene Therapy Manufacturing Services Consumption Value by Region (2018-2023)
        2.2.2 World Cell and Gene Therapy Manufacturing Services Consumption Value Forecast by Region (2024-2029)
    2.3 United States Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029)
    2.4 China Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029)
    2.5 Europe Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029)
    2.6 Japan Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029)
    2.7 South Korea Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029)
    2.8 ASEAN Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029)
    2.9 India Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029)

3 World Cell and Gene Therapy Manufacturing Services Companies Competitive Analysis
    3.1 World Cell and Gene Therapy Manufacturing Services Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cell and Gene Therapy Manufacturing Services Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy Manufacturing Services in 2022
        3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy Manufacturing Services in 2022
    3.3 Cell and Gene Therapy Manufacturing Services Company Evaluation Quadrant
    3.4 Cell and Gene Therapy Manufacturing Services Market: Overall Company Footprint Analysis
        3.4.1 Cell and Gene Therapy Manufacturing Services Market: Region Footprint
        3.4.2 Cell and Gene Therapy Manufacturing Services Market: Company Product Type Footprint
        3.4.3 Cell and Gene Therapy Manufacturing Services Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Cell and Gene Therapy Manufacturing Services Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cell and Gene Therapy Manufacturing Services Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Cell and Gene Therapy Manufacturing Services Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy Manufacturing Services Consumption Value Comparison
        4.2.1 United States VS China: Cell and Gene Therapy Manufacturing Services Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Cell and Gene Therapy Manufacturing Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Cell and Gene Therapy Manufacturing Services Companies and Market Share, 2018-2023
        4.3.1 United States Based Cell and Gene Therapy Manufacturing Services Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cell and Gene Therapy Manufacturing Services Revenue, (2018-2023)
    4.4 China Based Companies Cell and Gene Therapy Manufacturing Services Revenue and Market Share, 2018-2023
        4.4.1 China Based Cell and Gene Therapy Manufacturing Services Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cell and Gene Therapy Manufacturing Services Revenue, (2018-2023)
    4.5 Rest of World Based Cell and Gene Therapy Manufacturing Services Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Cell and Gene Therapy Manufacturing Services Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Cell and Gene Therapy Manufacturing Services Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Cell and Gene Therapy Manufacturing Services Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Allogeneic
        5.2.2 Autologous
        5.2.3 Viral Vector
    5.3 Market Segment by Type
        5.3.1 World Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023)
        5.3.2 World Cell and Gene Therapy Manufacturing Services Market Size by Type (2024-2029)
        5.3.3 World Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Cell and Gene Therapy Manufacturing Services Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Oncology Diseases
        6.2.2 Cardiovascular Diseases
        6.2.3 Orthopedic Diseases
        6.2.4 Ophthalmology Diseases
        6.2.5 Ophthalmology Diseases
        6.2.6 Others
    6.3 Market Segment by Application
        6.3.1 World Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023)
        6.3.2 World Cell and Gene Therapy Manufacturing Services Market Size by Application (2024-2029)
        6.3.3 World Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Thermo Fisher Scientific
        7.1.1 Thermo Fisher Scientific Details
        7.1.2 Thermo Fisher Scientific Major Business
        7.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product and Services
        7.1.4 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Thermo Fisher Scientific Recent Developments/Updates
        7.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
    7.2 Merck KGaA
        7.2.1 Merck KGaA Details
        7.2.2 Merck KGaA Major Business
        7.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Product and Services
        7.2.4 Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Merck KGaA Recent Developments/Updates
        7.2.6 Merck KGaA Competitive Strengths & Weaknesses
    7.3 Charles River Laboratories
        7.3.1 Charles River Laboratories Details
        7.3.2 Charles River Laboratories Major Business
        7.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product and Services
        7.3.4 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Charles River Laboratories Recent Developments/Updates
        7.3.6 Charles River Laboratories Competitive Strengths & Weaknesses
    7.4 Lonza
        7.4.1 Lonza Details
        7.4.2 Lonza Major Business
        7.4.3 Lonza Cell and Gene Therapy Manufacturing Services Product and Services
        7.4.4 Lonza Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Lonza Recent Developments/Updates
        7.4.6 Lonza Competitive Strengths & Weaknesses
    7.5 Catalent
        7.5.1 Catalent Details
        7.5.2 Catalent Major Business
        7.5.3 Catalent Cell and Gene Therapy Manufacturing Services Product and Services
        7.5.4 Catalent Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Catalent Recent Developments/Updates
        7.5.6 Catalent Competitive Strengths & Weaknesses
    7.6 WuXi AppTec
        7.6.1 WuXi AppTec Details
        7.6.2 WuXi AppTec Major Business
        7.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Product and Services
        7.6.4 WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 WuXi AppTec Recent Developments/Updates
        7.6.6 WuXi AppTec Competitive Strengths & Weaknesses
    7.7 Takara Bio Inc
        7.7.1 Takara Bio Inc Details
        7.7.2 Takara Bio Inc Major Business
        7.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product and Services
        7.7.4 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Takara Bio Inc Recent Developments/Updates
        7.7.6 Takara Bio Inc Competitive Strengths & Weaknesses
    7.8 Nikon Corporation
        7.8.1 Nikon Corporation Details
        7.8.2 Nikon Corporation Major Business
        7.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Product and Services
        7.8.4 Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Nikon Corporation Recent Developments/Updates
        7.8.6 Nikon Corporation Competitive Strengths & Weaknesses
    7.9 FUJIFILM Holdings Corporation
        7.9.1 FUJIFILM Holdings Corporation Details
        7.9.2 FUJIFILM Holdings Corporation Major Business
        7.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product and Services
        7.9.4 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 FUJIFILM Holdings Corporation Recent Developments/Updates
        7.9.6 FUJIFILM Holdings Corporation Competitive Strengths & Weaknesses
    7.10 F. Hoffmann-La Roche
        7.10.1 F. Hoffmann-La Roche Details
        7.10.2 F. Hoffmann-La Roche Major Business
        7.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product and Services
        7.10.4 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 F. Hoffmann-La Roche Recent Developments/Updates
        7.10.6 F. Hoffmann-La Roche Competitive Strengths & Weaknesses
    7.11 Oxford Biomedica Plc
        7.11.1 Oxford Biomedica Plc Details
        7.11.2 Oxford Biomedica Plc Major Business
        7.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product and Services
        7.11.4 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Oxford Biomedica Plc Recent Developments/Updates
        7.11.6 Oxford Biomedica Plc Competitive Strengths & Weaknesses
    7.12 Cell and Gene Therapy Catapult
        7.12.1 Cell and Gene Therapy Catapult Details
        7.12.2 Cell and Gene Therapy Catapult Major Business
        7.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product and Services
        7.12.4 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Cell and Gene Therapy Catapult Recent Developments/Updates
        7.12.6 Cell and Gene Therapy Catapult Competitive Strengths & Weaknesses
    7.13 The Discovery Labs LLC
        7.13.1 The Discovery Labs LLC Details
        7.13.2 The Discovery Labs LLC Major Business
        7.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product and Services
        7.13.4 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 The Discovery Labs LLC Recent Developments/Updates
        7.13.6 The Discovery Labs LLC Competitive Strengths & Weaknesses
    7.14 RoslinCT
        7.14.1 RoslinCT Details
        7.14.2 RoslinCT Major Business
        7.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Product and Services
        7.14.4 RoslinCT Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 RoslinCT Recent Developments/Updates
        7.14.6 RoslinCT Competitive Strengths & Weaknesses
    7.15 JRS PHARMA
        7.15.1 JRS PHARMA Details
        7.15.2 JRS PHARMA Major Business
        7.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Product and Services
        7.15.4 JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 JRS PHARMA Recent Developments/Updates
        7.15.6 JRS PHARMA Competitive Strengths & Weaknesses
    7.16 FinVector
        7.16.1 FinVector Details
        7.16.2 FinVector Major Business
        7.16.3 FinVector Cell and Gene Therapy Manufacturing Services Product and Services
        7.16.4 FinVector Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 FinVector Recent Developments/Updates
        7.16.6 FinVector Competitive Strengths & Weaknesses
    7.17 ABL
        7.17.1 ABL Details
        7.17.2 ABL Major Business
        7.17.3 ABL Cell and Gene Therapy Manufacturing Services Product and Services
        7.17.4 ABL Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 ABL Recent Developments/Updates
        7.17.6 ABL Competitive Strengths & Weaknesses
    7.18 Resilience
        7.18.1 Resilience Details
        7.18.2 Resilience Major Business
        7.18.3 Resilience Cell and Gene Therapy Manufacturing Services Product and Services
        7.18.4 Resilience Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 Resilience Recent Developments/Updates
        7.18.6 Resilience Competitive Strengths & Weaknesses
    7.19 BioCentriq
        7.19.1 BioCentriq Details
        7.19.2 BioCentriq Major Business
        7.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Product and Services
        7.19.4 BioCentriq Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.19.5 BioCentriq Recent Developments/Updates
        7.19.6 BioCentriq Competitive Strengths & Weaknesses
    7.20 Porton Biopharma Limited
        7.20.1 Porton Biopharma Limited Details
        7.20.2 Porton Biopharma Limited Major Business
        7.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product and Services
        7.20.4 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.20.5 Porton Biopharma Limited Recent Developments/Updates
        7.20.6 Porton Biopharma Limited Competitive Strengths & Weaknesses
    7.21 Andelyn Biosciences
        7.21.1 Andelyn Biosciences Details
        7.21.2 Andelyn Biosciences Major Business
        7.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product and Services
        7.21.4 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.21.5 Andelyn Biosciences Recent Developments/Updates
        7.21.6 Andelyn Biosciences Competitive Strengths & Weaknesses
    7.22 Commercializing Living Therapies
        7.22.1 Commercializing Living Therapies Details
        7.22.2 Commercializing Living Therapies Major Business
        7.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product and Services
        7.22.4 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.22.5 Commercializing Living Therapies Recent Developments/Updates
        7.22.6 Commercializing Living Therapies Competitive Strengths & Weaknesses
    7.23 Vibalogics
        7.23.1 Vibalogics Details
        7.23.2 Vibalogics Major Business
        7.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Product and Services
        7.23.4 Vibalogics Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.23.5 Vibalogics Recent Developments/Updates
        7.23.6 Vibalogics Competitive Strengths & Weaknesses
    7.24 Anemocyte Srl
        7.24.1 Anemocyte Srl Details
        7.24.2 Anemocyte Srl Major Business
        7.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product and Services
        7.24.4 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.24.5 Anemocyte Srl Recent Developments/Updates
        7.24.6 Anemocyte Srl Competitive Strengths & Weaknesses
    7.25 ElevateBio
        7.25.1 ElevateBio Details
        7.25.2 ElevateBio Major Business
        7.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Product and Services
        7.25.4 ElevateBio Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
        7.25.5 ElevateBio Recent Developments/Updates
        7.25.6 ElevateBio Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cell and Gene Therapy Manufacturing Services Industry Chain
    8.2 Cell and Gene Therapy Manufacturing Services Upstream Analysis
    8.3 Cell and Gene Therapy Manufacturing Services Midstream Analysis
    8.4 Cell and Gene Therapy Manufacturing Services Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cell and Gene Therapy Manufacturing Services Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Cell and Gene Therapy Manufacturing Services Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Cell and Gene Therapy Manufacturing Services Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Cell and Gene Therapy Manufacturing Services Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Cell and Gene Therapy Manufacturing Services Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Cell and Gene Therapy Manufacturing Services Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Cell and Gene Therapy Manufacturing Services Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Cell and Gene Therapy Manufacturing Services Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Cell and Gene Therapy Manufacturing Services Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Cell and Gene Therapy Manufacturing Services Players in 2022
    Table 12. World Cell and Gene Therapy Manufacturing Services Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Cell and Gene Therapy Manufacturing Services Company Evaluation Quadrant
    Table 14. Head Office of Key Cell and Gene Therapy Manufacturing Services Player
    Table 15. Cell and Gene Therapy Manufacturing Services Market: Company Product Type Footprint
    Table 16. Cell and Gene Therapy Manufacturing Services Market: Company Product Application Footprint
    Table 17. Cell and Gene Therapy Manufacturing Services Mergers & Acquisitions Activity
    Table 18. United States VS China Cell and Gene Therapy Manufacturing Services Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Cell and Gene Therapy Manufacturing Services Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Cell and Gene Therapy Manufacturing Services Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Cell and Gene Therapy Manufacturing Services Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Cell and Gene Therapy Manufacturing Services Revenue Market Share (2018-2023)
    Table 23. China Based Cell and Gene Therapy Manufacturing Services Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Cell and Gene Therapy Manufacturing Services Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Cell and Gene Therapy Manufacturing Services Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Cell and Gene Therapy Manufacturing Services Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Cell and Gene Therapy Manufacturing Services Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Cell and Gene Therapy Manufacturing Services Revenue Market Share (2018-2023)
    Table 29. World Cell and Gene Therapy Manufacturing Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Cell and Gene Therapy Manufacturing Services Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Cell and Gene Therapy Manufacturing Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Cell and Gene Therapy Manufacturing Services Market Size by Application (2024-2029) & (USD Million)
    Table 35. Thermo Fisher Scientific Basic Information, Area Served and Competitors
    Table 36. Thermo Fisher Scientific Major Business
    Table 37. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product and Services
    Table 38. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Thermo Fisher Scientific Recent Developments/Updates
    Table 40. Thermo Fisher Scientific Competitive Strengths & Weaknesses
    Table 41. Merck KGaA Basic Information, Area Served and Competitors
    Table 42. Merck KGaA Major Business
    Table 43. Merck KGaA Cell and Gene Therapy Manufacturing Services Product and Services
    Table 44. Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Merck KGaA Recent Developments/Updates
    Table 46. Merck KGaA Competitive Strengths & Weaknesses
    Table 47. Charles River Laboratories Basic Information, Area Served and Competitors
    Table 48. Charles River Laboratories Major Business
    Table 49. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product and Services
    Table 50. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Charles River Laboratories Recent Developments/Updates
    Table 52. Charles River Laboratories Competitive Strengths & Weaknesses
    Table 53. Lonza Basic Information, Area Served and Competitors
    Table 54. Lonza Major Business
    Table 55. Lonza Cell and Gene Therapy Manufacturing Services Product and Services
    Table 56. Lonza Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Lonza Recent Developments/Updates
    Table 58. Lonza Competitive Strengths & Weaknesses
    Table 59. Catalent Basic Information, Area Served and Competitors
    Table 60. Catalent Major Business
    Table 61. Catalent Cell and Gene Therapy Manufacturing Services Product and Services
    Table 62. Catalent Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Catalent Recent Developments/Updates
    Table 64. Catalent Competitive Strengths & Weaknesses
    Table 65. WuXi AppTec Basic Information, Area Served and Competitors
    Table 66. WuXi AppTec Major Business
    Table 67. WuXi AppTec Cell and Gene Therapy Manufacturing Services Product and Services
    Table 68. WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. WuXi AppTec Recent Developments/Updates
    Table 70. WuXi AppTec Competitive Strengths & Weaknesses
    Table 71. Takara Bio Inc Basic Information, Area Served and Competitors
    Table 72. Takara Bio Inc Major Business
    Table 73. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product and Services
    Table 74. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Takara Bio Inc Recent Developments/Updates
    Table 76. Takara Bio Inc Competitive Strengths & Weaknesses
    Table 77. Nikon Corporation Basic Information, Area Served and Competitors
    Table 78. Nikon Corporation Major Business
    Table 79. Nikon Corporation Cell and Gene Therapy Manufacturing Services Product and Services
    Table 80. Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Nikon Corporation Recent Developments/Updates
    Table 82. Nikon Corporation Competitive Strengths & Weaknesses
    Table 83. FUJIFILM Holdings Corporation Basic Information, Area Served and Competitors
    Table 84. FUJIFILM Holdings Corporation Major Business
    Table 85. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product and Services
    Table 86. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. FUJIFILM Holdings Corporation Recent Developments/Updates
    Table 88. FUJIFILM Holdings Corporation Competitive Strengths & Weaknesses
    Table 89. F. Hoffmann-La Roche Basic Information, Area Served and Competitors
    Table 90. F. Hoffmann-La Roche Major Business
    Table 91. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product and Services
    Table 92. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. F. Hoffmann-La Roche Recent Developments/Updates
    Table 94. F. Hoffmann-La Roche Competitive Strengths & Weaknesses
    Table 95. Oxford Biomedica Plc Basic Information, Area Served and Competitors
    Table 96. Oxford Biomedica Plc Major Business
    Table 97. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product and Services
    Table 98. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Oxford Biomedica Plc Recent Developments/Updates
    Table 100. Oxford Biomedica Plc Competitive Strengths & Weaknesses
    Table 101. Cell and Gene Therapy Catapult Basic Information, Area Served and Competitors
    Table 102. Cell and Gene Therapy Catapult Major Business
    Table 103. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product and Services
    Table 104. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Cell and Gene Therapy Catapult Recent Developments/Updates
    Table 106. Cell and Gene Therapy Catapult Competitive Strengths & Weaknesses
    Table 107. The Discovery Labs LLC Basic Information, Area Served and Competitors
    Table 108. The Discovery Labs LLC Major Business
    Table 109. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product and Services
    Table 110. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. The Discovery Labs LLC Recent Developments/Updates
    Table 112. The Discovery Labs LLC Competitive Strengths & Weaknesses
    Table 113. RoslinCT Basic Information, Area Served and Competitors
    Table 114. RoslinCT Major Business
    Table 115. RoslinCT Cell and Gene Therapy Manufacturing Services Product and Services
    Table 116. RoslinCT Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. RoslinCT Recent Developments/Updates
    Table 118. RoslinCT Competitive Strengths & Weaknesses
    Table 119. JRS PHARMA Basic Information, Area Served and Competitors
    Table 120. JRS PHARMA Major Business
    Table 121. JRS PHARMA Cell and Gene Therapy Manufacturing Services Product and Services
    Table 122. JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. JRS PHARMA Recent Developments/Updates
    Table 124. JRS PHARMA Competitive Strengths & Weaknesses
    Table 125. FinVector Basic Information, Area Served and Competitors
    Table 126. FinVector Major Business
    Table 127. FinVector Cell and Gene Therapy Manufacturing Services Product and Services
    Table 128. FinVector Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. FinVector Recent Developments/Updates
    Table 130. FinVector Competitive Strengths & Weaknesses
    Table 131. ABL Basic Information, Area Served and Competitors
    Table 132. ABL Major Business
    Table 133. ABL Cell and Gene Therapy Manufacturing Services Product and Services
    Table 134. ABL Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. ABL Recent Developments/Updates
    Table 136. ABL Competitive Strengths & Weaknesses
    Table 137. Resilience Basic Information, Area Served and Competitors
    Table 138. Resilience Major Business
    Table 139. Resilience Cell and Gene Therapy Manufacturing Services Product and Services
    Table 140. Resilience Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 141. Resilience Recent Developments/Updates
    Table 142. Resilience Competitive Strengths & Weaknesses
    Table 143. BioCentriq Basic Information, Area Served and Competitors
    Table 144. BioCentriq Major Business
    Table 145. BioCentriq Cell and Gene Therapy Manufacturing Services Product and Services
    Table 146. BioCentriq Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 147. BioCentriq Recent Developments/Updates
    Table 148. BioCentriq Competitive Strengths & Weaknesses
    Table 149. Porton Biopharma Limited Basic Information, Area Served and Competitors
    Table 150. Porton Biopharma Limited Major Business
    Table 151. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product and Services
    Table 152. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 153. Porton Biopharma Limited Recent Developments/Updates
    Table 154. Porton Biopharma Limited Competitive Strengths & Weaknesses
    Table 155. Andelyn Biosciences Basic Information, Area Served and Competitors
    Table 156. Andelyn Biosciences Major Business
    Table 157. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product and Services
    Table 158. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 159. Andelyn Biosciences Recent Developments/Updates
    Table 160. Andelyn Biosciences Competitive Strengths & Weaknesses
    Table 161. Commercializing Living Therapies Basic Information, Area Served and Competitors
    Table 162. Commercializing Living Therapies Major Business
    Table 163. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product and Services
    Table 164. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 165. Commercializing Living Therapies Recent Developments/Updates
    Table 166. Commercializing Living Therapies Competitive Strengths & Weaknesses
    Table 167. Vibalogics Basic Information, Area Served and Competitors
    Table 168. Vibalogics Major Business
    Table 169. Vibalogics Cell and Gene Therapy Manufacturing Services Product and Services
    Table 170. Vibalogics Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 171. Vibalogics Recent Developments/Updates
    Table 172. Vibalogics Competitive Strengths & Weaknesses
    Table 173. Anemocyte Srl Basic Information, Area Served and Competitors
    Table 174. Anemocyte Srl Major Business
    Table 175. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product and Services
    Table 176. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 177. Anemocyte Srl Recent Developments/Updates
    Table 178. ElevateBio Basic Information, Area Served and Competitors
    Table 179. ElevateBio Major Business
    Table 180. ElevateBio Cell and Gene Therapy Manufacturing Services Product and Services
    Table 181. ElevateBio Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 182. Global Key Players of Cell and Gene Therapy Manufacturing Services Upstream (Raw Materials)
    Table 183. Cell and Gene Therapy Manufacturing Services Typical Customers
List of Figure
    Figure 1. Cell and Gene Therapy Manufacturing Services Picture
    Figure 2. World Cell and Gene Therapy Manufacturing Services Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Cell and Gene Therapy Manufacturing Services Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Cell and Gene Therapy Manufacturing Services Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Cell and Gene Therapy Manufacturing Services Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Cell and Gene Therapy Manufacturing Services Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Cell and Gene Therapy Manufacturing Services Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Cell and Gene Therapy Manufacturing Services Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Cell and Gene Therapy Manufacturing Services Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Cell and Gene Therapy Manufacturing Services Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Cell and Gene Therapy Manufacturing Services Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Cell and Gene Therapy Manufacturing Services Revenue (2018-2029) & (USD Million)
    Figure 13. Cell and Gene Therapy Manufacturing Services Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Cell and Gene Therapy Manufacturing Services Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Cell and Gene Therapy Manufacturing Services Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Cell and Gene Therapy Manufacturing Services by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy Manufacturing Services Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy Manufacturing Services Markets in 2022
    Figure 27. United States VS China: Cell and Gene Therapy Manufacturing Services Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Cell and Gene Therapy Manufacturing Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Cell and Gene Therapy Manufacturing Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type in 2022
    Figure 31. Allogeneic
    Figure 32. Autologous
    Figure 33. Viral Vector
    Figure 34. World Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2029)
    Figure 35. World Cell and Gene Therapy Manufacturing Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application in 2022
    Figure 37. Oncology Diseases
    Figure 38. Cardiovascular Diseases
    Figure 39. Orthopedic Diseases
    Figure 40. Ophthalmology Diseases
    Figure 41. Infectious Diseases
    Figure 42. Others
    Figure 43. Cell and Gene Therapy Manufacturing Services Industrial Chain
    Figure 44. Methodology
    Figure 45. Research Process and Data Source